MeiraGTx Share Price

MeiraGTx Share Price

NASDAQ: MGTX | Healthcare
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

MeiraGTx Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

MeiraGTx Share Price Chart

$0.00$0.00
L
Show Current Price
H

MeiraGTx Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
10.47
Dividend Yield
0.00%
EPS (TTM)
$0.81
Revenue (TTM)
$81.39B
Return On Equity (TTM)
36.64%
Profit Margin
-140.31%
Debt to Equity
0.56
Quarterly Earnings Growth YoY
418.19%

MeiraGTx Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.41$75.36$0.29$321.43
Net Profit-$50.51$15.09-$46.31$160.72
Net Profit Margin-12319.51%20.02%-15968.97%50.00%
Income ChangeN/A129.88%-406.89%447.05%

MeiraGTx Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$15.92$14.02$33.28$81.39
Net Profit-$129.62-$84.03-$147.79-$114.20
Net Profit Margin-814.20%-599.36%-444.08%-140.31%
Income ChangeN/A35.17%-75.88%22.73%

MeiraGTx Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets152.67146.23167.12163.9
Current Assets91.76123.52159.62154.34
Total Assets244.43269.75326.74318.24
Non Current Liabilities127.67141.14121.49118.43
Current Liabilities122.5660.7867.0882.07
Total Liabilities250.22201.92188.57200.5
Shareholders' Equity-5.7967.83138.18117.74

MeiraGTx Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-46.36-104.5-105.37-73.1
Investing-4.1123.4834.03-44.96
Financing12.2754.5384.0295.2

About MeiraGTx

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

MeiraGTx Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %

MeiraGTx Share Price FAQs